Client News

APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China

Imcyse SA: Imcyse to present late-breaking abstract of its Imotope™-based antigen-specific immunotherapy for autoimmune diseases at ASIT 2020

4basebio AG announces allotment ratio and final number of shares for the share buy back

Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock

Verona Pharma to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update

InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

CENTOGENE AG: Illness is more than suffering: CENTOGENE Launches Annual International Rare Disease Film Festival

Rentschler Biopharma Adds Senior Executive to Growing U.S. Team